
Pharmacologic Therapy for Heart Failure with Preserved Ejection Fraction.
Publication
, Journal Article
Peters, AE; DeVore, AD
Published in: Cardiol Clin
November 2022
The management of heart failure with preserved ejection fraction (HFpEF) is rapidly evolving. The pharmacologic treatment of patients with HFpEF includes symptom management with diuretics and optimization of comorbidities, including hypertension, obesity, diabetes mellitus, and atrial fibrillation. Specific therapies, including angiotensin II receptor blockers, mineralocorticoid receptor antagonists, angiotensin receptor-neprilysin inhibitors, and sodium-glucose cotransporter-2 inhibitors, are well tolerated and can reduce the risk of HF hospitalization, particularly in those on the lower end of the HFpEF left ventricular ejection fraction spectrum. Ongoing trials should continue to inform optimal therapy in this evolving field.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Cardiol Clin
DOI
EISSN
1558-2264
Publication Date
November 2022
Volume
40
Issue
4
Start / End Page
473 / 489
Location
Netherlands
Related Subject Headings
- Ventricular Function, Left
- Stroke Volume
- Sodium-Glucose Transporter 2 Inhibitors
- Sodium
- Receptors, Angiotensin
- Neprilysin
- Mineralocorticoid Receptor Antagonists
- Humans
- Heart Failure
- Glucose
Citation
APA
Chicago
ICMJE
MLA
NLM
Peters, A. E., & DeVore, A. D. (2022). Pharmacologic Therapy for Heart Failure with Preserved Ejection Fraction. Cardiol Clin, 40(4), 473–489. https://doi.org/10.1016/j.ccl.2022.06.004
Peters, Anthony E., and Adam D. DeVore. “Pharmacologic Therapy for Heart Failure with Preserved Ejection Fraction.” Cardiol Clin 40, no. 4 (November 2022): 473–89. https://doi.org/10.1016/j.ccl.2022.06.004.
Peters AE, DeVore AD. Pharmacologic Therapy for Heart Failure with Preserved Ejection Fraction. Cardiol Clin. 2022 Nov;40(4):473–89.
Peters, Anthony E., and Adam D. DeVore. “Pharmacologic Therapy for Heart Failure with Preserved Ejection Fraction.” Cardiol Clin, vol. 40, no. 4, Nov. 2022, pp. 473–89. Pubmed, doi:10.1016/j.ccl.2022.06.004.
Peters AE, DeVore AD. Pharmacologic Therapy for Heart Failure with Preserved Ejection Fraction. Cardiol Clin. 2022 Nov;40(4):473–489.

Published In
Cardiol Clin
DOI
EISSN
1558-2264
Publication Date
November 2022
Volume
40
Issue
4
Start / End Page
473 / 489
Location
Netherlands
Related Subject Headings
- Ventricular Function, Left
- Stroke Volume
- Sodium-Glucose Transporter 2 Inhibitors
- Sodium
- Receptors, Angiotensin
- Neprilysin
- Mineralocorticoid Receptor Antagonists
- Humans
- Heart Failure
- Glucose